Patents Assigned to Elpis Biopharmaceuticals
  • BISPECIFIC CHIMERIC ANTIGEN RECEPTORS BINDING TO CD19 AND CD22
    Publication number: 20240082402
    Abstract: Bi-specific chimeric antigen receptors (CARs) capable of binding to both CD19 and CD22 and immune cells expressing such. Also provided herein are therapeutic uses of such immune cells (e.g., CAR-T cells) for eliminating disease cells such as cancer cells.
    Type: Application
    Filed: January 21, 2022
    Publication date: March 14, 2024
    Applicant: Elpis Biopharmaceuticals
    Inventors: Yan CHEN, Jenna NGUYEN, Kehao ZHAO, Keming ZHANG
  • ANTI-SARS-CoV-2 ANTIBODIES AND USES THEREOF
    Publication number: 20230220053
    Abstract: Disclosed herein are anti-SARS-CoV-2 spike protein antibodies and methods of using such for therapeutic and/or diagnostic purposes. Also provided herein are methods for producing such antibodies.
    Type: Application
    Filed: May 17, 2021
    Publication date: July 13, 2023
    Applicant: Elpis Biopharmaceuticals
    Inventors: Yan CHEN, Kehao ZHAO, Jenna NGUYEN, Ning JIANG